Boehringer Ingelheim Pharmaceuticals, Inc. v. U.S. Federal Trade Commission

Jones Day represented Boehringer Ingelheim Pharmaceuticals, Inc. The U.S. Federal Trade Commission (“FTC”) ended an 11-year investigation into the settlements of two Hatch-Waxman patent infringement lawsuits…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now